Knockout(KO) Cell Lines: CRISPR-U™ Technology

Scientist.com
Approved Supplier
×

Subscribe Us

By subscription, you consent to allow Ubigene Biosciences to store and process the information provided above to deliver the latest news, research spotlight, and promotions. You can unsubscribe from these communications at anytime.

Location: Home > Gene Editing Services > Stable Cell Lines > Knockout Cell Lines

Gene Knockout Cell Line

Knockout cell lines serve as crucial research models, widely used in exploring gene functions, disease mechanisms, and drug target screening. By simulating the effects of gene deletion on cellular behavior, it can reveal the roles of specific genes in biological processes and their significance in disease development.

Based on the CRISPR-U™ technique, Ubigene selects appropriate transfection methods (electroporation or viral transduction) according to different cell characteristics to transfer gRNA and Cas9 into cells. Subsequently, single-cell clone screening is performed, and positive clones that are successfully knocked out will be validated by target site amplification and sequencing. Final deliverables will be the homozygous KO cell clones, related data, and project reports.

View all
img1 img2

CRISPR-U™ Technique

CRISPR-U™ is the technique developed by Ubigene for gene editing in cell lines (based on CRISPR/Cas9). It includes a unique algorithm for designing gRNA based on cell genome characteristics, methods for exploring different gene-editing parameters for thousands of cell lines, precise detection of the editing efficiency of Cell Pool, methods for improving single-cell clone formation rates, and high-throughput identification of cellular genotypes.

icon1
icon1
Exclusive innovative technique, Gene-editing efficiency improved by 10-20 times
icon2
icon2
Fast and precise identification
Saving 4 weeks to screen positive clones
icon3
icon3
300+ Success gene-editing cell lines
6000+ Success cases

Knockout Cell Service

Cell type Various types of cells including tumor cell lines, regular cell lines, IPS/ES cell lines
Service type Single / Multiple Genes Knockout
Deliverables Cell pool / Single-cell clone
Turnaround/Price Turnaround Speedy turnaround as fast as 4 weeks!
Contact Us Contact Us

300+Successful
Gene-editing Cell Line Types

Respiratory System
+
Human Lung Cancer Cell Line(A549)Human Lung Cancer Cell Line(NCI-H1299)Human Lung Cancer Cell Line(NCI-H520)Human Lung Cancer Cell Line(SK-MES-1)Mouse Lewis lung carcinoma Cell Line(LLC)Human Bronchial Epithelial Cell Line(BEAS-2B)Human Lung Cancer Cell Line(HCC827)Porcine alveolar macrophage cell line(3D4/21)Human lung adenocarcinoma cell line(PC9)Human Lung Cancer Cell Line(NCI-H1650)Human Lung Cancer Cell Line(NCI-H727)Human lung adenocarcinoma cell line(NCI-H1975)Human lung cancer cell line(NCI-H292)Human Lung Cancer Cell Line(NCI-H23)Human Lung Cancer Cell Line(MSTO-211H)Human Lung Cancer Cell Line(NCI-H358)Human Non-small Cell Lung Carcinoma Cell Line(NCI-H460)Human lung adenocarcinoma cell line(Calu-3)Human Fetal Lung Fibroblast Cell Line(MRC-5)Human Highly Metastatic Lung Cancer Cell Line(95-D)Human Colon Carcinoma Cell Line(T84)MLE-12 Cell Complete Medium(MLE-12)Human Fetal Lung Fibroblast Cell Line(WI-38)Human Lung Cancer Cell Line(DMS114)Human lung adenocarcinoma cell line(NCI-H1373)Human Lung Cancer Cell Line(NCI-H1703)Human Lung Cancer Cell Line(DMS 53)Human Small Cell Lung Cancer Cell Line(NCI-H82 [H82])Human Small Cell Lung Cancer Cell Line(SHP-77)Human Lung Cancer Cell Line(NCI-H2170)
Circulatory System
+
Rat Cardiac Myocytes(H9c2(2-1))Mouse Myoblast Cell Line(C2C12)Human Cardiac Myocytes(AC16)Mouse Aortic Smooth Muscle Cell Line(MOVAS)
Endocrine System
+
Human Submandibular Gland Epidermoid Carcinoma Cell Line(A-253)Human Mammary Epithelial Cell Line(MCF 10A)Human Breast Cancer Cell Line(MDA-MB-231)Human Breast Cancer Cell Line(MCF7)Human Breast Cancer Cell Line(MDA-MB-415)Human Breast Cancer Cell Line(MDA-MB-468)Human Breast Epithelial Cell Line Integrating SV40 Gene(HBL-100)Human Prostate Cancer Cell Line(LNCaP Clone FGC)Human Prostate Cancer Cell Line(PC-3)Human Prostate Cancer Cell Line(22RV1)Human pancreatic cancer cell line(BxPC-3)Mouse Breast Cancer Cell Line(4T1)Mouse Acinar Pancreatic Cell Line(266-6)Human Breast Cancer Cell Line(JIMT-1)Mouse prostate cancer cell line(RM-1)Human Breast Cancer Cell Line(SK-BR-3)Human Breast Cancer Cell Line(HCC1806)Human Thyroid Normal Cell Line(Nthy-ori 3-1)Mouse pancreatic cancer cell line(Pan-02)Human Pancreatic Carcinoma Cell Line(SW1990)Human acute lymphoblastic leukemia cell line(MOLT4)Human Pancreatic Carcinoma Cell Line(Panc-1)Mouse Breast Adenocarcinoma Cell Line(E0771)Human Thyroid Squamous Cell Carcinoma Cell line(SW579)Human Breast Cancer Cell Line(HCC1143)Human breast cancer cell line(BT-549)Human acute lymphoblastic leukemia cell line(MT-4)Py230 Cell Line(Py230)Human Thyroid Cancer Cell Line(TPC-1)Human Prostate Cancer Cell Line(PC-3M)Human Burkitt's Lymphoma Cell Line(RAJI)Human Metastatic Pancreatic Adenocarcinoma Cell Line(AsPC-1)Human NK Leukemia Cell Line(YT)Human Prostate Cancer Cell Line(DU145)Mouse Mammary Epithelial Cell Line(HC11)Mouse Breast Cancer Cell Line(C127)Human Thyroid Normal Cell Line(Nthy-ori 3-1)Human Pancreatic Carcinoma Cell Line(MIA PaCa-2)Mouse Breast Cancer Cell Line(EMT6)Human Prostate Cancer Cell Line(VCaP)Human Breast Cancer Cell Line(SUM-149PT)Human breast ductal cancer cell Line(BT474)Human Pancreatic Carcinoma Cell Line(Capan2)
Brain and Nervous System
+
Rat Glioblastoma Cell Line(C6)Mouse Hippocampal Neuronal Cell Line(HT-22)Human Neuroblastoma Cell Line(SK-N-SH)Human Neuroblastoma Cell Line(SH-SY5Y)Human glioblastoma cell line(U-87 MG)Human glioblastoma cell line(U251MG)Mouse Anterior Parietal Bone Cell Line(MC3T3-E1 Subclone 14)Mouse microglia cell line(BV2)Human microglial clone 3 cell line(HMC3)Mouse neuroblastoma cell line(Neuro-2a)Human glioblastoma cell line(LN-229)Mouse Glioblastoma Cell Line(GL261)Human Glioblastoma Cell Line(T98G)Human Glioblastoma Cell Line(A-172)Human Neuroblastoma Cell Line(SK-N-BE(2))Human Brain Astrocytoma Cell Line(Hs 683)Rat Glioblastoma Cell Line(RG2)
Blood and lymphatic System
+
Mouse Hybridoma Cell Line(AE-1)Hybridoma (Anti-Cd3) Cell Line(OKT 3)Human Monocytic Cell Line(THP-1)Human Histiocytic Lymphoma Cell Line(U-937)Human T Lymphocyte Cell Line(Jurkat, Clone E6-1)Human Acute Lymphocyte Cell Line(OCI-Aml-3)Human myelogenous Leukemia Cell Line(K-562)Mouse Macrophage Cell Line(RAW 264.7)Human Acute Promyelocytic Leukemia Cell Line(HL-60)Human B Lymphoma Cell Line(U-2932)Mouse B Lymphoma Cell Line(A20)Human Myelomonocytic Leukemia Cell Line(MV4-11)Human B Lymphoma Cell Line(SU-DHL-4)Human Acute Myeloid Leukemia Cell Line(KG-1a)Human Erythroleukemia Cell Line(HEL)Mouse Pro B Cell Line(BAF3)Human acute promyelocytic leukemia cell line(NB4)Human T-lymphocyte Cell Line(Hut-78)Human B Lymphocytes Cell Line(GM12878)Mouse Lymphoma Cell Line(EL4)Mouse Macrophage Cell Line(Ana-1)Human Erythroleukemia Cell Line(TF-1)Human Lymphoma Cell Line(BC-3)Human Multiple Myeloma Peripheral Blood B Lymphocytes(RPMI 8226)Human Burkitt's Lymphoma B Lymphocytes(Ramos)Human B lymphoma cell line(SU-DHL-6)Human Acute Lymphoblastic Leukemia Cell Line (Non-B Non-T)(Reh)Human?Acute?Lymphocyte?Cell?Line(Kasumi-1)Human Mantle Cell Lymphoma Cell Line(JeKo-1)Human peripheral blood mantle lymphoma Cell Line(Mino)Human Acute Myeloid Leukemia Cell Line(MOLM13)Human B lymphocytic leukaemia Cell Line(NALM-6)Human B lymphoma cell line(SU-DHL-8)
Urinary System
+
African green monkey kidney cell(Vero)African green monkey kidney cell(VERO C1008 (E6))Dog Kidney Cell Line(MDCK(NBL-2))Human Embryonic Kidney Cell Line(293T)Human Embryonic Kidney Cell Line(293T)Human Embryonic Kidney Cell Line(HEK293)Rat adrenal pheochromocytoma cell line(Low differentiation)(PC-12)Human Bladder Transitional Cell Carcinoma Cell Line(T24)Human bladder carcinoma cell line(5637)Mouse Bladder Cancer Cell(MB-49)Human renal cell carcinoma cell line(786-0)Human renal cell carcinoma cell line(MS751)Mouse podocyte cell line(MPC-5)Pig Kidney Cell  line(PK-15)Human Embryonic Kidney Cell Line(2V6.11)Human Bladder Transitional Cell Carcinoma Cell Line(SW780)Transformed (SV40) African Green Monkey Kidney Cell Line(COS-1)Transformed (SV40) African Green Monkey Kidney Cell Line(COS-7)Rat Kidney Cell Line(NRK-52E)Mouse Renal Adenocarcinoma Cell Line(RenCa)Bovine Kidney (MDBK) Cell Line(MDBK (NBL-1))Hamster Kidney Fibroblasts(BHK-21)Human Renal Proximal Tubular Epithelial Cell Line(HK-2)Human Urinary Bladder Squamous Cell Carcinoma Cell Line(SCaBER)Mouse Renal Adenocarcinoma Cell Line(RAG)Mouse Bladder Cancer Cell(MBT-2)Human renal carcinoma cell line(OS-RC-2)
Digestive System
+
Human Gallbladder Carcinoma Cell Line(GBC-SD)Human Hepatoma Cell Line(Hep G2)Human Hepatoma Cell Line(SNU-387)Human Hepatoma Cell Line(HuH-7)Human Hepatoma Cell Line(SK-HEP-1)Human Hepatoma Cell Line(Hep 3B)Human Normal Hepatocytes Cell line(L-02)Human Colon Cancer Cell Line(HCT 116)Human Colon Cancer Cell Line(HT-29)Human colorectal adenocarcinoma cell line(RKO)Human colorectal adenocarcinoma cell line(Caco-2)Human Esophageal Squamous Carcinoma Cell Line(KYSE-150)Human gastric cancer cell line(AGS)Mouse Hepatocarcinoma Cell Line(Hepa 1-6)Murine colorectal carcinoma cell line(CT26.WT)Murine colorectal carcinoma cell line(MC38)Human Esophageal Squamous Carcinoma Cell Line(KYSE-30)Mouse Hepatocarcinoma Cell Line(H22)Human Gastric Cancer Cell Line(NCI-N87)Human colorectal adenocarcinoma cell line(SW480)Human Hepatoma Cell Line(SMMC-7721)Porcine intestinal epithelial cell line(IPEC-J2)Human Gastric Cancer Cell Line(HGC-27)Human Gastric Cancer Cell Line(MGC-803)Human renal carcinoma cell line(ACHN)Human colorectal adenocarcinoma cell line(LS 174T)Immortalized Human Hepatic Cell Line(C3A)Human Hepatoma Cell Line(PLC/PRF/5)Human colorectal adenocarcinoma cell line(SW 48)Human colorectal adenocarcinoma cell line(SW948)Human colorectal adenocarcinoma cell line(NCI-H716)Mouse hepatocyte cell line(AML12)Human Gastric Cancer Cell Line(SGC-7901)Human Ileocecal Cancer Cell Line(HRT-18)Human Colon Cancer Cell Line(LoVo)Human Hepatoma Cell Line(MHCC97-H)Human Gastric Cancer Cell Line(MKN-45)Human Colon Cancer Cell Line(COLO 205)Rat Liver Cell Line(BRL)Mouse Gastric Cancer Cell Line(MFC)Human Colon Cancer Cell Line(SW620)Human Hepatoma Cell Line(Li-7)Mouse Ascites Sarcoma Cell Line(S180)Rat Liver Cell Line(BRL-3A)Human Colon Cancer Cell Line(HCT-15)Human Gastric Cancer Cell Line(KATO III)Human colorectal adenocarcinoma cell line(SW1463)Human Gastric Cancer Cell Line(SNU-5)Human colorectal adenocarcinoma cell line(SW1116 [SW 1116, SW-1116])Human Hepatic Stellate Cell Line(LX-2)Human Hepatoma Cell Line(HCCLM3)
Skeleton, Articulus, Soft Tissue, Derma System
+
Human Umbilical Vein Cell Line(EA.hy926)Mouse Lewis lung carcinoma Cell Line(U-2 OS)Human Osteosarcoma Cell Line(Saos-2)Human skin squamous carcinoma cell line(A-431)Murine melanoma cell line(B16-F10)Human malignant melanoma cell line(A-375)Human Skin Fibroblast Cell Line(BJ)Mouse Fibroblast Cell Line(L-929)Mouse Lewis lung carcinoma Cell Line(SW 1353)Human fibrosarcoma cell line(HT-1080)Rat osteosarcoma cell line(UMR-106)Human Immortalized Keratinocytes Cell line(HaCaT)Chicken Fibroblast Cell line(DF1)Human Multiple Myeloma Cell Line(MM.1S)Human Corneal Epithelial Cell Line(HCE-T)(HCE-T)Immortalized Human Lens Epithelial Adherent Cell Line(SRA01/04)Mouse Lewis lung carcinoma Cell Line(MG-63)Mouse Osteosarcoma Cell Line(K7M2-WT)Mouse Lewis lung carcinoma Cell Line(143B)Mouse Subcutaneous Connective Tissue Cell Line(A9)Mouse squamous carcinoma cell line(SCC-7)Human Choriocarcinoma Cell Line(JAR)Human bone osteosarcoma epithelial cell line(KHOS-240S)Mouse Chondrogenic Cell Line(ATDC5)
Ocular, Otolaryngologic and Oral System
+
Human Pharyngeal Carcinoma Cell Line (Pleural Effusion Metastasis)(Detroit 562)Human retinal pigment epithelial cell line(ARPE-19)Human Nasopharyngeal Carcinoma Cell Line(CNE1)Human oral squamous carcinoma cell line(HSC3)Human nasopharyngeal carcinoma cell line(HK-1)Human oral squamous carcinoma cell line(CAL-27)Mouse Cochlear Hair Cell Line(HEI-OC1)Human Retinoblastoma Cell Line(Y79)Human Tongue Squamous Carcinoma Cell Line(SCC-9)Human Pharyngeal Squamous Cell Carcinoma Cell Line(FaDu)
Reproductive System
+
Human Amniotic Cell Line(WISH)Human Highly Metastatic Ovarian Cancer Cell Line(HO-8910PM)African green monkey kidney cell Line(Marc-145)Human Cervical Carcinoma Cell Line(Hela)Human ovarian cancer cell line(OVCAR-3)Human Ovarian Adenocarcinoma Cell Line(Caov-3)Mouse Embryonic Fibroblasts(NIH/3T3)Mouse Fibroblast Cell Line(TM3)Human Villous Trophoblast(HTR-8/SVneo)Human Ovarian Granulosa Cell Line(KGN)Chinese Hamster Ovary Cell Line(CHO-K1)Human Endometrial Adenocarcinoma Cell Line(MFE-280)Mouse ovarian epithelial cancer Cell(ID8)Human endometrial adenocarcinoma cell(HEC-1-B)Human Endometrial Carcinoma Cell Line (ISHIKAWA)Human Cervical Carcinoma Cell Line(C-33 A)Human Cervical Carcinoma Cell Line(Ca Ski)Human Endometrial Carcinoma Cell Line (KLE)Mouse Teratocarcinoma Cell Line(P19)Human Ovarian Clear Cell Carcinoma Cell Line(ES-2)Human Endometrial Adenocarcinoma Cell Line(AN3 CA)Human Cervical Carcinoma Cell Line(hela 229)Human Ovarian Adenocarcinoma Cell Line(SK-OV-3)Human Choriocarcinoma Cell Line(Bewo)
Stem Cell
+
Stem Cell(H9)Human Embryonic Stem Cell(H1)Induced Pluripotent Stem Cell(ipsc)

Knockout Strategies

Short fragment removal
Short fragment removal
Guide RNAs target introns at both sides of exon 2 and the number of bases in exon 2 is not a multiple of 3, which can cause frame-shift mutation.
Frame-shift mutation
Frame-shift mutation
Guide RNA targets the exon, and the base number of deletion is not a multiple of 3. After knockout, frame-shift mutation would cause gene knockout.
Large fragment removal
Large fragment removal
Complete removal of the coding sequence to achieve gene knockout.
img2
View Picture
Short fragment removal
Short fragment removal
01
Guide RNAs target introns at both sides of exon 2 and the number of bases in exon 2 is not a multiple of 3, which can cause frame-shift mutation.
Frame-shift mutation
Frame-shift mutation
02
Guide RNA targets the exon, and the base number of deletion is not a multiple of 3. After knockout, frame-shift mutation would cause gene knockout.
Large fragment removal
Large fragment removal
03
Complete removal of the coding sequence to achieve gene knockout.
img2

Work Flow and Validation

Strategy Design by
Red Cotton System
RNP Complex Cell Transfection
PRC Amplification Single-cell Cloning Pool Efficiency
Validation
Sanger Sequencing
Validation
QC & Cell
Cryopreservation

FAQs

1
How long does CRISPR gene knockout take?

Typical Timeline for CRISPR Gene Knockout

The timeline for a CRISPR gene knockout can vary depending on the organism and specific experimental setup, typically ranging from a few weeks to several months. Here’s a general breakdown of the process:

  • gRNA Design and Plasmid Construction (1–2 weeks)
  • Cell Line Transfection & Pool Screening (2–3 weeks)
  • Single-Cell Cloning (2–4 weeks)
  • Clone Validation (2–3 weeks)

With 12 years of expertise in gene editing, Ubigene expert team has optimized the entire workflow, reducing the KO cell generation timeline to as fast as 4 weeks — significantly accelerating your research progress. Connect with Ubigene's experts now to customize your exclusive KO cell line!

2
What are the difference between KO cells and Knockdown cells?

Feature Knockout (KO) Knockdown (KD)
Mechanism CRISPR, ZFNs, TALENs (genome editing) RNAi (siRNA, shRNA)
Effect on Gene Expression Complete loss Partial reduction
Permanence Permanent Usually transient (shRNA can be stable)
Protein Production No protein produced Reduced protein levels
Suitability Studying complete gene loss, long-term studies Studying gene function, short-term studies, essential genes
Best For Disease models, drug discovery, functional genomics Quick functional validation, gene pathway studies

3
Is gene knockout permanent?

Gene knockout (KO) is typically permanent, especially when using genome-editing techniques like CRISPR-Cas9. Here's why:

  • Mechanism: In gene knockout, a DNA double-strand break is introduced at a specific location in the gene. This break is repaired by the cell’s own repair mechanisms, which often result in insertions or deletions (indels) and introduce an early stop codon,that disrupt the gene's coding sequence, causing it to lose its function. These mutations are passed on to daughter cells when they divide.
  • Permanent in Cell Lines: If you're generating a knockout in a cell line, the knockout is usually stable over time, as the altered DNA will be present in every cell, and the mutation is passed down with cell division. You can even create clonal populations where all cells carry the same knockout mutation.
  • Permanent in Organisms: If you’re creating a knockout in an organism (such as mice or other model organisms), the gene disruption will be passed on through heredity if the knockout is done in germline cells (e.g., sperm or eggs), leading to permanent knockouts in offspring. In some cases, you might generate heterozygous knockouts first, and then breed them to produce homozygous knockouts for more complete disruption.

4
What is the purpose of a gene knockout

The purpose of a gene knockout (KO) is to study the function of a specific gene by completely eliminating its expression or disrupting its function. By knocking out a gene, researchers can observe how the organism or cell behaves in the absence of that gene's product (usually the protein it encodes). This helps answer key biological questions and has a wide range of applications

5
How to confirm gene knockout?

1. Molecular Confirmation Methods:

  • a) PCR and Gel Electrophoresis
  • b) Sequencing
  • c) Southern Blotting
  • d) Western Blotting (Protein Level Confirmation)
  • e) qRT-PCR (Quantitative Reverse Transcription PCR

2. Functional Assays:

  • a) Phenotypic Analysis
  • b) Reporter Genes
  • c) Flow Cytometry (for Knockout Cells)

3. Knockout Mouse/Model Organism Specific Verification:

  • a) Breeding and Genotyping (for Mice or Other Organisms)
  • b) Histological Analysis

Selected KO-cited papers

PPP1R12B/KCNJ12/FGA knockout Hep G2 cell line-liver tumors
IF=64.8
Nature
PPP1R12B/KCNJ12/FGA knockout Hep G2 cell line-liver tumors
IF=64.8 Nature
STING1 Knockout in HeLa cell line——prevention and treatment of viral diseases
IF=32.4
Immunity
STING1 Knockout in HeLa cell line——prevention and treatment of viral diseases
IF=32.4 Immunity
TP53 Knockout in HCT116 cell line——Apoptosis
IF=16.6
Nature Communications
TP53 Knockout in HCT116 cell line——Apoptosis
IF=16.6 Nature Communications
Abstract:
In this study, the HCT116 cell line with TP53 gene knocked out constructed by Ubigene was used. By analyzing the crystal structure of the complex of p53 and the anti-apoptotic protein BCL-2, and combining biochemical and cellular experiments, this study revealed a new mechanism of p53 interacting with BCL-2 protein and promoting apoptosis, that is, p53 forms a complex with BCL-2 by directly occupying the BH3-binding pocket of BCL-2, and antagonizes BCL-2 activity by releasing pro-apoptotic BCL-2 family proteins located in the pocket, thereby promoting apoptosis[2].These structural and functional data provide a new idea for further understanding the complex regulatory mechanism of p53-mediated mitochondrial apoptosis, and also provide an important basis for developing anticancer therapeutic strategies that target protein-protein interactions to activate apoptosis. View details>>
Mutations in p53 interacting with BCL-2 reduce apoptosis
Mutations in p53 interacting with BCL-2 reduce apoptosis
ZNF432 knockout U2OS cell line——Ovarian cancer drug resistance
IF=14.9
Nucleic Acids Research
ZNF432 knockout U2OS cell line——Ovarian cancer drug resistance
IF=14.9 Nucleic Acids Research
Abstract:
ZNF protein was confirmed as a key factor regulating the genome integrity of mammalian cells. In order to explore the possibility that ZFP can be used as an effector of DNA repair based on homologous recombination (HR), Jean Yves Masson[3] team of Laval University used the ZNF432 knockout U2OS cell line constructed by Ubigene to carry out a series of experiments, and found that ZNF432 deletion in cancer cells would accelerate DNA repair, lead to the weakening of PARPi effect, and make ovarian cancer cells develop drug resistance, confirming that ZNF432 is a new HR inhibitor, which successfully broadened the new way to study the efficacy of PARPi. View details>>
Regulation of ZNF432 expression affects drug resistance of ovarian cancer cells
Regulation of ZNF432 expression affects drug resistance of ovarian cancer cells
SNORD17 Knockout in HepG2 cell line——liver tumors
IF=12.4
Cell death & differentiation
SNORD17 Knockout in HepG2 cell line——liver tumors
IF=12.4 Cell death & differentiation
Abstract:
This study reveals the regulatory role of small nucleolar RNA SNORD17 and p53 pathway in hepatocellular carcinoma, which provides a new potential target for the treatment of hepatocellular carcinoma[5] . The researchers utilized SNORD17 knockout Hep G2 cell line (constructed by Ubigene) as the key cell model. After applied with in vitro and in vivo tests, they found out that in HCC cell lines, the knockout of SNORD17 gene can significantly inhibit cell proliferation, clone formation and G1/S phase transition. View details>>
p53 mediates SNORD17 to affect HCC cell growth
p53 mediates SNORD17 to affect HCC cell growth
Pik3r1 knockout RAW264.7 cell line - Osteoporosis
IF=11.4
Redox Biology
Pik3r1 knockout RAW264.7 cell line - Osteoporosis
IF=11.4 Redox Biology
Abstract:
This article explores a new mechanism for GSTP1 affecting the osteoclast cell-related bone homeostasis through combining with a large number of in vivo and in vitro experiments, based on the Pik3r1 knockout RAW264.7 cell model constructed by Ubigene. It was the first time to interpret that the cell fate of osteoclasts is determined by S-glutathionylation via a redox-autophagy which is mediated by GSTP1. View details>>
SiNPs induces CASA mechanism
SiNPs induces CASA mechanism

Contact us

If we are unable to reach you via email, how else can we contact you?

Contact us

Contact us

If we are unable to reach you via email, how else can we contact you?
Submission Succeeded
×

Search documentation

Literature:

Name: *

Company: *

Telephone: *

Email:

Notes: After submitting the order, we will contact you as soon as possible.

request now

Latest Promotion

NEW

Hot Deal!KO Cells Starting at Just $990

Promotion Price: $990